Strategic Intelligence: Artificial Intelligence in Healthcare (2025)
Description
Strategic Intelligence: Artificial Intelligence in Healthcare (2025)
Summary
Artificial intelligence (AI) is transforming healthcare through automation, analytics, and smarter clinical tools. Across healthcare providers, pharmaceuticals, and medical devices, the combined AI market was valued at $11.9 billion in 2024 and is expected to reach $57.4 billion by 2029, representing a compound annual growth rate (CAGR) of about 37%.
AI consulting and support services are driving healthcare’s administrative automation and clinical decision support. AI hardware, including robotics and imaging systems, underpins advances in the medical device sector, while AI platforms and specialized applications are reshaping pharmaceutical research and development (R&D). Collectively, these technologies are moving AI from pilots to scaled commercial adoption.
Scope
Summary
Artificial intelligence (AI) is transforming healthcare through automation, analytics, and smarter clinical tools. Across healthcare providers, pharmaceuticals, and medical devices, the combined AI market was valued at $11.9 billion in 2024 and is expected to reach $57.4 billion by 2029, representing a compound annual growth rate (CAGR) of about 37%.
AI consulting and support services are driving healthcare’s administrative automation and clinical decision support. AI hardware, including robotics and imaging systems, underpins advances in the medical device sector, while AI platforms and specialized applications are reshaping pharmaceutical research and development (R&D). Collectively, these technologies are moving AI from pilots to scaled commercial adoption.
Scope
- AI adoption is accelerating across healthcare sectors.
- AI boosts efficiency in drug discovery and development.
- Regulatory progress accelerates adoption of AI imaging tools.
- Understand how AI is being used in the healthcare sector.
- Learn about the major players in AI in healthcare, and where the future of AI in healthcare is going.
- Access valuable strategic information to enhance future decision-making and inform new product development.
Table of Contents
- Executive Summary
- Players
- Value Chain
- Advanced AI capabilities
- The Impact of AI on Healthcare
- Healthcare providers, payors, service providers, and suppliers
- Pharma
- Medical devices
- How AI helps tackle the challenge of drug discovery and development
- How AI helps tackle the challenge of low success rates of clinical trials
- How AI tackles the challenge of drug safety and pharmacovigilance
- How AI tackles the challenge of precision and personalized medicine
- How AI helps tackle the challenge of staff shortages and administrative efficacy
- How AI helps tackle the challenge of medical imaging and diagnosis
- Case Studies
- Pfizer and XtalPi expand collaboration on AI in small-molecule drug discovery
- SkyCell and Microsoft expand AI integration in pharma supply chains
- Medtronic and Methinks partner to improve stroke detection and treatment
- GE Healthcare partners with Nvidia on AI X-ray and ultrasound solutions
- MedImpact launches AI plate scanner
- Companies
- Leading AI adopters in healthcare
- Specialist AI vendors in healthcare
- Sector Scorecards
- Drug development sector scorecard
- Who’s who
- Thematic screen
- Valuation screen
- Risk screen
- Medical devices sector scorecard
- Who’s who
- Thematic screen
- Valuation screen
- Risk screen
- Glossary
- Further Reading
- GlobalData reports
- Our Thematic Research Methodology
- About GlobalData
- Contact Us
- List of Tables
- Table 1: Leading AI adopters in healthcare
- Table 2: Specialist AI vendors in healthcare
- Table 3: Glossary
- Table 4: GlobalData reports
- List of Figures
- Figure 1: Key players in AI
- Figure 2: The AI value chain
- Figure 3: There are five categories of advanced AI capabilities
- Figure 4: Thematic investment matrix - AI in healthcare
- Figure 5: Thematic investment matrix - AI in pharma
- Figure 6: Thematic investment matrix - AI in medical devices
- Figure 7: Pfizer and XtalPi expanded their collaboration in drug discovery
- Figure 8: SkyCell and Microsoft expand AI integration
- Figure 9: Medtronic and Methinks AI partner to improve stroke care
- Figure 10: GE Healthcare partners with Nvidia on AI autonomous imaging
- Figure 11: MedImpact’s new AI plate scanner
- Figure 12: Who does what in the drug development space?
- Figure 13: Thematic screen - Drug development sector scorecard
- Figure 14: Valuation screen - Drug development sector scorecard
- Figure 15: Risk screen - Drug development sector scorecard
- Figure 16: Who does what in the medical devices space?
- Figure 17: Thematic screen - Medical devices sector scorecard
- Figure 18: Valuation screen - Medical devices sector scorecard
- Figure 19: Risk screen - Medical devices sector scorecard
- Figure 20: Our five-step approach for generating a sector scorecard
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
